ArticleCancer pathogenesis and therapy2024

Inetetamab combined with pyrotinib and oral vinorelbine for patients with human epidermal growth factor receptor 2 positive advanced breast cancer: A single-arm phase 2 clinical trial.

Nan Jin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.